Literature DB >> 28100833

Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies.

Constantinos Petrovas1, Sara Ferrando-Martinez2, Michael Y Gerner3, Joseph P Casazza2, Amarendra Pegu4, Claire Deleage5, Arik Cooper4, Jason Hataye2, Sarah Andrews6, David Ambrozak2, Perla M Del Río Estrada7, Eli Boritz8, Robert Paris9, Eirini Moysi2, Kristin L Boswell2, Ezequiel Ruiz-Mateos10, Ilias Vagios11, Manuel Leal10, Yuria Ablanedo-Terrazas7, Amaranta Rivero7, Luz Alicia Gonzalez-Hernandez7, Adrian B McDermott6, Susan Moir12, Gustavo Reyes-Terán7, Fernando Docobo10, Giuseppe Pantaleo13, Daniel C Douek8, Michael R Betts14, Jacob D Estes5, Ronald N Germain3, John R Mascola4, Richard A Koup2.   

Abstract

Cytolytic CD8 T cells play a crucial role in the control and elimination of virus-infected cells and are a major focus of HIV cure efforts. However, it has been shown that HIV-specific CD8 T cells are infrequently found within germinal centers (GCs), a predominant site of active and latent HIV infection. We demonstrate that HIV infection induces marked changes in the phenotype, frequency, and localization of CD8 T cells within the lymph node (LN). Significantly increased frequencies of CD8 T cells in the B cell follicles and GCs were found in LNs from treated and untreated HIV-infected individuals. This profile was associated with persistent local immune activation but did not appear to be directly related to local viral replication. Follicular CD8 (fCD8) T cells, despite compromised cytokine polyfunctionality, showed good cytolytic potential characterized by high ex vivo expression of granzyme B and perforin. We used an anti-HIV/anti-CD3 bispecific antibody in a redirected killing assay and found that fCD8 T cells had better killing activity than did non-fCD8 T cells. Our results indicate that CD8 T cells with potent cytolytic activity are recruited to GCs during HIV infection and, if appropriately redirected to kill HIV-infected cells, could be an effective component of an HIV cure strategy.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28100833      PMCID: PMC5497679          DOI: 10.1126/scitranslmed.aag2285

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  59 in total

Review 1.  Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy.

Authors:  Luca Gattinoni; Yun Ji; Nicholas P Restifo
Journal:  Clin Cancer Res       Date:  2010-08-05       Impact factor: 12.531

2.  Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.

Authors:  Deborah L Regidor; Roger Detels; Elizabeth C Breen; Daniel P Widney; Lisa P Jacobson; Frank Palella; Charles R Rinaldo; Jay H Bream; Otoniel Martínez-Maza
Journal:  AIDS       Date:  2011-01-28       Impact factor: 4.177

3.  Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques.

Authors:  Yin Xu; Chris Weatherall; Michelle Bailey; Sheilajen Alcantara; Robert De Rose; Jerome Estaquier; Kim Wilson; Kazuo Suzuki; Jacques Corbeil; David A Cooper; Stephen J Kent; Anthony D Kelleher; John Zaunders
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

4.  Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells.

Authors:  George Makedonas; Natalie Hutnick; Danielle Haney; Alexandra C Amick; Jay Gardner; Gabriela Cosma; Adam R Hersperger; Douglas Dolfi; E John Wherry; Guido Ferrari; Michael R Betts
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

5.  Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes.

Authors:  Michael Y Gerner; Wolfgang Kastenmuller; Ina Ifrim; Juraj Kabat; Ronald N Germain
Journal:  Immunity       Date:  2012-08-02       Impact factor: 31.745

6.  Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients.

Authors:  K Tenner-Racz; P Racz; C Thomé; C G Meyer; P J Anderson; S F Schlossman; N L Letvin
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

7.  Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.

Authors:  Kai Deng; Mihaela Pertea; Anthony Rongvaux; Leyao Wang; Christine M Durand; Gabriel Ghiaur; Jun Lai; Holly L McHugh; Haiping Hao; Hao Zhang; Joseph B Margolick; Cagan Gurer; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Steven G Deeks; Till Strowig; Priti Kumar; Janet D Siliciano; Steven L Salzberg; Richard A Flavell; Liang Shan; Robert F Siliciano
Journal:  Nature       Date:  2015-01-07       Impact factor: 49.962

8.  Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21.

Authors:  Suresh Pallikkuth; Luca Micci; Zachary S Ende; Robin I Iriele; Barbara Cervasi; Benton Lawson; Colleen S McGary; Kenneth A Rogers; James G Else; Guido Silvestri; Kirk Easley; Jacob D Estes; Francois Villinger; Savita Pahwa; Mirko Paiardini
Journal:  PLoS Pathog       Date:  2013-07-04       Impact factor: 6.823

9.  Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production.

Authors:  Matthieu Perreau; Anne-Laure Savoye; Elisa De Crignis; Jean-Marc Corpataux; Rafael Cubas; Elias K Haddad; Laurence De Leval; Cecilia Graziosi; Giuseppe Pantaleo
Journal:  J Exp Med       Date:  2012-12-17       Impact factor: 14.307

10.  Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells.

Authors:  Derek D Sloan; Chia-Ying Kao Lam; Alivelu Irrinki; Liqin Liu; Angela Tsai; Craig S Pace; Jasmine Kaur; Jeffrey P Murry; Mini Balakrishnan; Paul A Moore; Syd Johnson; Jeffrey L Nordstrom; Tomas Cihlar; Scott Koenig
Journal:  PLoS Pathog       Date:  2015-11-05       Impact factor: 6.823

View more
  82 in total

1.  Long-Term Persistence of Anti-HIV Broadly Neutralizing Antibody-Secreting Hematopoietic Cells in Humanized Mice.

Authors:  Anne-Sophie Kuhlmann; Kevin G Haworth; Isaac M Barber-Axthelm; Christina Ironside; Morgan A Giese; Christopher W Peterson; Hans-Peter Kiem
Journal:  Mol Ther       Date:  2018-09-27       Impact factor: 11.454

2.  Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation.

Authors:  James W Austin; Clarisa M Buckner; Lela Kardava; Wei Wang; Xiaozhen Zhang; Valerie A Melson; Ryan G Swanson; Andrew J Martins; Julian Q Zhou; Kenneth B Hoehn; J Nicholas Fisk; Yiannis Dimopoulos; Alexander Chassiakos; Sijy O'Dell; Margery G Smelkinson; Catherine A Seamon; Richard W Kwan; Michael C Sneller; Stefania Pittaluga; Nicole A Doria-Rose; Adrian McDermott; Yuxing Li; Tae-Wook Chun; Steven H Kleinstein; John S Tsang; Constantinos Petrovas; Susan Moir
Journal:  Sci Transl Med       Date:  2019-11-27       Impact factor: 17.956

Review 3.  Follicular T-cell subsets in HIV infection: recent advances in pathogenesis research.

Authors:  Yin Xu; Matthew T Ollerton; Elizabeth Connick
Journal:  Curr Opin HIV AIDS       Date:  2019-03       Impact factor: 4.283

4.  Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.

Authors:  Ann J Hessell; Mariya B Shapiro; Rebecca Powell; Delphine C Malherbe; Sean P McBurney; Shilpi Pandey; Tracy Cheever; William F Sutton; Christoph Kahl; Byung Park; Susan Zolla-Pazner; Nancy L Haigwood
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

5.  Depletion of Gut-Resident CCR5+ Cells for HIV Cure Strategies.

Authors:  David Merriam; Connie Chen; Gema Méndez-Lagares; Kenneth A Rogers; Anthony J Michaels; Jiangli Yan; Paul Casaz; Keith A Reimann; François Villinger; Dennis J Hartigan-O'Connor
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11       Impact factor: 2.205

Review 6.  T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics.

Authors:  Z Wu; N V Cheung
Journal:  Pharmacol Ther       Date:  2017-08-20       Impact factor: 12.310

7.  T Cells in Nonlymphoid Tissues Give Rise to Lymph-Node-Resident Memory T Cells.

Authors:  Lalit K Beura; Sathi Wijeyesinghe; Emily A Thompson; Marissa G Macchietto; Pamela C Rosato; Mark J Pierson; Jason M Schenkel; Jason S Mitchell; Vaiva Vezys; Brian T Fife; Steven Shen; David Masopust
Journal:  Immunity       Date:  2018-02-20       Impact factor: 31.745

Review 8.  Why and where an HIV cure is needed and how it might be achieved.

Authors:  Thumbi Ndung'u; Joseph M McCune; Steven G Deeks
Journal:  Nature       Date:  2019-12-18       Impact factor: 49.962

Review 9.  Bispecific antibodies: Potential immunotherapies for HIV treatment.

Authors:  Giulia Fabozzi; Amarendra Pegu; Richard A Koup; Constantinos Petrovas
Journal:  Methods       Date:  2018-10-22       Impact factor: 3.608

10.  Recombinant Human Interleukin-15 and Anti-PD-L1 Combination Therapy Expands a CXCR3+PD1-/low CD8 T-Cell Subset in Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Ping Chen; Hui Chen; Maha Moussa; Jie Cheng; Tong Li; Jing Qin; Jeffrey D Lifson; Michael C Sneller; Ludmila Krymskaya; Steven Godin; H Clifford Lane; Marta Catalfamo
Journal:  J Infect Dis       Date:  2020-02-03       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.